User profiles for Utkarsh Agrawal

Utkarsh Agrawal

- Verified email at phc.ox.ac.uk - Cited by 2790

Utkarsh Agrawal

- Verified email at kitp.ucsb.edu - Cited by 359

Generalized hydrodynamics, quasiparticle diffusion, and anomalous local relaxation in random integrable spin chains

U Agrawal, S Gopalakrishnan, R Vasseur - Physical Review B, 2019 - APS
We study the nonequilibrium dynamics of random spin chains that remain integrable (ie,
solvable via Bethe ansatz): because of correlations in the disorder, these systems escape …

Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in …

…, V Boaventura, GL Werneck, R Flores-Ortiz, U Agrawal… - The Lancet, 2022 - thelancet.com
Background Reports suggest that COVID-19 vaccine effectiveness is decreasing, but whether
this reflects waning or new SARS-CoV-2 variants—especially delta (B.1.617.2)—is unclear…

Noninteger-spin magnonic excitations in untextured magnets

A Kamra, U Agrawal, W Belzig - Physical Review B, 2017 - APS
Interactions are responsible for intriguing physics, eg, the emergence of exotic ground states
and excitations, in a wide range of systems. Here, we theoretically demonstrate that dipole-…

[HTML][HTML] Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

E Vasileiou, CR Simpson, T Shi, S Kerr, U Agrawal… - The Lancet, 2021 - thelancet.com
Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca)
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …

Optimized Binary Bat algorithm for classification of white blood cells

D Gupta, J Arora, U Agrawal, A Khanna… - Measurement, 2019 - Elsevier
The quantitative and differential analysis of leukocytes present in human body provide conducive
hematological information to physicians for diagnosis of various infections and ailments…

Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality

…, CR Simpson, MD Muckian, U Agrawal… - BMC infectious …, 2021 - Springer
Background Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) has challenged
public health agencies globally. In order to effectively target government responses, it is …

[HTML][HTML] Effectiveness of first dose of COVID-19 vaccines against hospital admissions in Scotland: national prospective cohort study of 5.4 million people

…, CR Simpson, C Robertson, T Shi, S Kerr, U Agrawal… - 2021 - papers.ssrn.com
Background: The BNT162b2 mRNA (Pfizer-BioNTech) and ChAdOx1 (Oxford-AstraZeneca)
COVID-19 vaccines have demonstrated high efficacy against infection in phase 3 clinical …

SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland

…, T McLaughlin, J Pan, T Shi, B Taylor, U Agrawal… - Nature medicine, 2022 - nature.com
Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

…, S Kerr, E Moore, C McCowan, U Agrawal… - Nature medicine, 2021 - nature.com
Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events
have led to some countries restricting its use. Using a national prospective cohort, we …

[HTML][HTML] Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million …

U Agrawal, S Bedston, C McCowan, J Oke, L Patterson… - The Lancet, 2022 - thelancet.com
Background Current UK vaccination policy is to offer future COVID-19 booster doses to
individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of …